Incyte Says Opzelura Cream Approved in EU to Treat Moderate Atopic Dermatitis
RegulatoryapprovedOpzelura CreamPositive
AI Analysis
Summary
Incyte announced EU approval of Opzelura Cream for the treatment of moderate atopic dermatitis, representing a regulatory milestone for the company's dermatology portfolio.
Outcome Details
EU approval for Opzelura Cream for moderate atopic dermatitis
Importance:8/10
Sentiment:
0.80
regulatory_approvaldermatologyEU_approvalOpzelura
Related Companies
Read the original article
Published by yahoo_finance on July 29, 2026 1:51 PM